查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587499

組織工程市場規模、佔有率、趨勢分析報告：按應用、地區、細分市場預測，2025-2030 年

Tissue Engineering Market Size, Share & Trends Analysis Report By Application (Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Orthopedics, Musculoskeletal, & Spine, Urology), By Region And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

組織工程市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球組織工程市場規模預計將達到431.3億美元，2025年至2030年複合年成長率預計為14.3%。

心血管疾病、糖尿病和整形外科疾病等慢性疾病的增加增加了對修復或替換受損組織的組織工程解決方案的需求。生物材料、3D 生物列印、幹細胞研究和基因編輯技術的進步正在推動組織工程領域的發展，並促進複雜功能組織的發展。

同種異體組織移植技術有效地解決了與自體移植的使用和可近性相關的挑戰和限制。此外，旨在將同種異體植入轉化為生物植入的植入固定和滅菌等專門程序的進步預計將推動該市場的收益。

組織再生技術因其有效的產品和低排斥率而越來越受歡迎，從而導致再生治療的增加。目前臨床前研究的重點是組織工程血管移植物在心血管手術和治療的使用。此外，組織工程膀胱現已成功植入患者體外。儘管取得了這些進步，但市場成長仍受到產品開發成本高以及幹細胞研究和組織工程產品倫理問題等挑戰的阻礙。

組織工程市場報告亮點

  • 由於肌肉骨骼疾病的盛行率不斷增加，整形外科、肌肉骨骼和脊椎領域的收益最大，2024 年市場佔有率為 59.21%。
  • 北美市場佔據主導地位，2024 年銷售佔有率最大，為 51.30%。這是由於人們對幹細胞治療認知的提高、老年人口的增加以及慢性病盛行率的上升。
  • 在市場估計和預測期內，亞太地區的組織工程市場預計複合年成長率為19.04%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章組織工程市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 組織工程市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第4章 應用業務分析

  • 細分儀表板
  • 全球組織工程市場應用變遷分析
  • 2018-2030年全球組織工程市場規模及趨勢分析（按應用）
  • 臍帶血和細胞庫
  • 癌症
  • 胃腸科/婦科
  • 牙科
  • 皮膚和體被
  • 泌尿系統
  • 整形外科、肌肉骨骼、脊柱
  • 神經病學
  • 心血管醫學
  • 其他

第5章區域業務分析

  • 區域儀表板
  • 組織工程市場：2024 年和 2030 年按地區分類的佔有率
  • 北美洲
    • 北美組織工程市場，2018-2030
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲組織工程市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 亞太組織工程市場，2018-2030
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲組織工程市場，2018-2030
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲組織工程市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 公司/競爭對手分類
  • 策略規劃
  • 2024年企業定位分析
  • 公司簡介/名單
    • Zimmer Biomet Holdings, Inc.
    • AbbVie（Allergan）
    • Becton, Dickinson and Company
    • B. Braun
    • Integra LifeSciences Corporation
    • Organogenesis Holdings Inc.
    • Medtronic
    • ACell, Inc.
    • Athersys, Inc.
    • Tissue Regenix Group plc
    • Stryker Corporation
    • RTI Surgical, Inc.
    • ReproCell, Inc.
    • Baxter International, Inc.
Product Code: 978-1-68038-768-1

Tissue Engineering Market Growth & Trends:

The global tissue engineering market size is estimated to reach USD 43.13 billion by 2030, growing at an estimated CAGR of 14.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of chronic diseases, such as cardiovascular diseases, diabetes, and orthopedic disorders, has driven the demand for tissue engineering solutions that can repair or replace damaged tissues. Advances in biomaterials, 3D bioprinting, stem cell research, and gene editing techniques have propelled the field of tissue engineering, enabling the development of complex and functional tissues.

The allogeneic tissue transplant method effectively addresses the challenges and limitations associated with the use and accessibility of autologous transplants. In addition, the advancement of specialized procedures, such as implant fixing and sterilization, aimed at converting allogeneic implants into biostatic implants, is anticipated to boost revenue generation in this market.

Tissue regeneration technology is gaining popularity due to its effective products and low rejection rates, leading to an increase in regeneration treatments. Pre-clinical research is currently focused on the use of tissue-engineered vascular grafts in cardiovascular surgery and treatment. Moreover, tissue-engineered bladders can now be successfully implanted outside of the patient's body. Despite these advancements, the market's growth is hindered by challenges such as the high cost of product development and ethical concerns surrounding stem cell research and tissue-engineered products.

Tissue Engineering Market Report Highlights:

  • The orthopedics, musculoskeletal, & spine segment held the largest revenue of 59.21% market share in 2024, owing to the increasing prevalence of musculoskeletal disorders.
  • North America dominated the market and accounted for the largest revenue share of 51.30% in 2024, owing to rising awareness of stem cell therapy, the growing geriatric population, and the rising incidence of chronic diseases.
  • The market for tissue engineering in Asia Pacific is estimated to witness the fastest CAGR of 19.04% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Tissue Engineering Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in stem cell technology & tissue engineering
      • 3.2.1.2. Rise in number of clinical studies for Tissue Engineering and tissue engineering
      • 3.2.1.3. Increasing tissue engineering research funding
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of product development
      • 3.2.2.2. Ethical concerns related to stem cell research & tissue engineered product
      • 3.2.2.3. Clinical issues pertaining to development & implementation of stem cell therapies
  • 3.3. Tissue Engineering Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Tissue Engineering Market Application Movement Analysis
  • 4.3. Global Tissue Engineering Market Size & Trend Analysis, by Specimen, 2018 to 2030 (USD Million)
  • 4.4. Cord blood & Cell banking
    • 4.4.1. Cord blood & Cell banking market estimates and forecast 2018 - 2030 (USD Million)
  • 4.5. Cancer
    • 4.5.1. Cancer market estimates and forecast 2018 - 2030 (USD Million)
  • 4.6. GI/Gynecology
    • 4.6.1. GI/Gynecology therapy market estimates and forecast 2018 - 2030 (USD Million)
  • 4.7. Dental
    • 4.7.1. Dental market estimates and forecast 2018 - 2030 (USD Million)
  • 4.8. Skin & Integumentary
    • 4.8.1. Skin & Integumentary market estimates and forecast 2018 - 2030 (USD Million)
  • 4.9. Urology
    • 4.9.1. Urology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.10. Orthopedics, Musculoskeletal, & Spine
    • 4.10.1. Orthopedics, Musculoskeletal, & Spine market estimates and forecast 2018 - 2030 (USD Million)
  • 4.11. Neurology
    • 4.11.1. Neurology market estimates and forecast 2018 - 2030 (USD Million)
  • 4.12. Cardiology & Vascular
    • 4.12.1. Cardiology & Vascular market estimates and forecast 2018 - 2030 (USD Million)
  • 4.13. Others
    • 4.13.1. Others market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Dashboard
  • 5.2. Tissue Engineering Market: Share By Region, 2024 & 2030
  • 5.3. North America
    • 5.3.1. North America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Mexico Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Sweden Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Norway Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Denmark Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. China Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Japan Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Australia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Thailand Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. South Korea Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Brazil Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Argentina Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. South Africa Tissue Engineering Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. Saudi Arabia Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. UAE Tissue Engineering Testing Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Kuwait Tissue Engineering Testing Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Position Analysis, 2024
  • 6.4. Company Profiles/Listing
    • 6.4.1. Zimmer Biomet Holdings, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. AbbVie (Allergan)
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Becton, Dickinson and Company
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. B. Braun
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Integra LifeSciences Corporation
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Organogenesis Holdings Inc.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. ACell, Inc.
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Athersys, Inc.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Tissue Regenix Group plc
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Stryker Corporation
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. RTI Surgical, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. ReproCell, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Baxter International, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global tissue engineering market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 12 Germany tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 14 France tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 17 Sweden tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 18 Norway tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 19 Denmark tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 21 APAC tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 22 China tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 23 Japan tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 24 India tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 30 Argentina tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 31 Middle East and Africa tissue engineering market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East and Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 33 South Africa tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 35 UAE tissue engineering market, by application, 2018 - 2030 (USD Million)
  • Table 36 Kuwait tissue engineering market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tissue engineering: market outlook
  • Fig. 9 Tissue engineering competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tissue engineering market driver impact
  • Fig. 15 Tissue engineering market restraint impact
  • Fig. 16 Tissue engineering market strategic initiatives analysis
  • Fig. 17 Global tissue engineering market: application movement analysis
  • Fig. 18 Global tissue engineering market: application outlook and key takeaways
  • Fig. 19 Global cord blood & Cell Banking market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 20 Global cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global GI, Gynecology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Global dental market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Global skin & Integumentary market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global urology market estimates and forecast, 2018 - 2030, (USD Million)
  • Fig. 25 Global orthopedics, Musculoskeletal, & Spine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global cardiology & Vascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Global tissue engineering market: regional movement analysis
  • Fig. 30 Global tissue engineering market: regional outlook and key takeaways
  • Fig. 31 Global market share and leading players
  • Fig. 32 North America market, SWOT analysis
  • Fig. 33 Europe market, SWOT analysis
  • Fig. 34 Asia Pacific market, SWOT analysis
  • Fig. 35 Latin America market, SWOT analysis
  • Fig. 36 Middle East & Africa market, SWOT analysis
  • Fig. 37 North America
  • Fig. 38 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Participant categorization- Tissue engineering market
  • Fig. 67 Market position of key market players- Tissue engineering market